File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1161/CIRCRESAHA.110.222794
- Scopus: eid_2-s2.0-77958496539
- PMID: 20724703
- WOS: WOS:000282965300007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: Implications on hypertension
Title | Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: Implications on hypertension | ||||||
---|---|---|---|---|---|---|---|
Authors | |||||||
Keywords | bone morphogenic protein 4 cyclooxygenase-2 endothelial dysfunction endothelium-dependent contractions reactive oxygen species | ||||||
Issue Date | 2010 | ||||||
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://circres.ahajournals.org | ||||||
Citation | Circulation Research, 2010, v. 107 n. 8, p. 984-991 How to Cite? | ||||||
Abstract | Rationale: Bone morphogenic protein (BMP)4 can stimulate superoxide production and exert proinflammatory effects on the endothelium. The underlying mechanisms of how BMP4 mediates endothelial dysfunction and hypertension remain elusive. Objective: To elucidate the cellular pathways by which BMP4-induced endothelial dysfunction is mediated through oxidative stress-dependent upregulation of cyclooxygenase (COX)-2. Methods and Results: Impaired endothelium-dependent relaxations, exaggerated endothelium-dependent contractions, and reactive oxygen species (ROS) production were observed in BMP4-treated mouse aortae, which were prevented by the BMP4 antagonist noggin. Pharmacological inhibition with thromboxane prostanoid receptor antagonist or COX-2 but not COX-1 inhibitor prevented BMP4-induced endothelial dysfunction, which was further confirmed with the use of COX-1-/- or COX-2 -/- mice. Noggin and knockdown of BMP receptor 1A abolished endothelium-dependent contractions and COX-2 upregulation in BMP4-treated aortae. Apocynin and tempol treatment were effective in restoring endothelium-dependent relaxations, preventing endothelium-dependent contractions and eliminating ROS overproduction and COX-2 overexpression in BMP4-treated aortae. BMP4 increased p38 mitogen-activated protein kinase (MAPK) activity through a ROS-sensitive mechanism and p38 MAPK inhibitor prevented BMP4-induced endothelial dysfunction. COX-2 inhibition blocked the effect of BMP4 without affecting BMP4-induced ROS overproduction and COX-2 upregulation. Importantly, renal arteries from hypertensive rats and humans showed higher levels of COX-2 and BMP4 accompanied by endothelial dysfunction. Conclusions: We show for the first time that ROS serve as a pathological link between BMP4 stimulation and the downstream COX-2 upregulation in endothelial cells, leading to endothelial dysfunction through ROS-dependent p38 MAPK activation. This BMP4/ROS/COX-2 cascade is important in the maintenance of endothelial dysfunction in hypertension. © 2010 American Heart Association. All rights reserved. | ||||||
Persistent Identifier | http://hdl.handle.net/10722/149751 | ||||||
ISSN | 2023 Impact Factor: 16.5 2023 SCImago Journal Rankings: 4.903 | ||||||
ISI Accession Number ID |
Funding Information: This work was supported by the Hong Kong Research Grant Council (CUHK465308, CUHK466110, and HKU 2/07C) and CUHK Focused Investment Scheme. | ||||||
References | |||||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, WT | en_HK |
dc.contributor.author | Tian, XY | en_HK |
dc.contributor.author | Chen, Y | en_HK |
dc.contributor.author | Leung, FP | en_HK |
dc.contributor.author | Liu, L | en_HK |
dc.contributor.author | Lee, HK | en_HK |
dc.contributor.author | Ng, CF | en_HK |
dc.contributor.author | Xu, A | en_HK |
dc.contributor.author | Yao, X | en_HK |
dc.contributor.author | Vanhoutte, PM | en_HK |
dc.contributor.author | Tipoe, GL | en_HK |
dc.contributor.author | Huang, Y | en_HK |
dc.date.accessioned | 2012-06-26T05:58:03Z | - |
dc.date.available | 2012-06-26T05:58:03Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | Circulation Research, 2010, v. 107 n. 8, p. 984-991 | en_HK |
dc.identifier.issn | 0009-7330 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/149751 | - |
dc.description.abstract | Rationale: Bone morphogenic protein (BMP)4 can stimulate superoxide production and exert proinflammatory effects on the endothelium. The underlying mechanisms of how BMP4 mediates endothelial dysfunction and hypertension remain elusive. Objective: To elucidate the cellular pathways by which BMP4-induced endothelial dysfunction is mediated through oxidative stress-dependent upregulation of cyclooxygenase (COX)-2. Methods and Results: Impaired endothelium-dependent relaxations, exaggerated endothelium-dependent contractions, and reactive oxygen species (ROS) production were observed in BMP4-treated mouse aortae, which were prevented by the BMP4 antagonist noggin. Pharmacological inhibition with thromboxane prostanoid receptor antagonist or COX-2 but not COX-1 inhibitor prevented BMP4-induced endothelial dysfunction, which was further confirmed with the use of COX-1-/- or COX-2 -/- mice. Noggin and knockdown of BMP receptor 1A abolished endothelium-dependent contractions and COX-2 upregulation in BMP4-treated aortae. Apocynin and tempol treatment were effective in restoring endothelium-dependent relaxations, preventing endothelium-dependent contractions and eliminating ROS overproduction and COX-2 overexpression in BMP4-treated aortae. BMP4 increased p38 mitogen-activated protein kinase (MAPK) activity through a ROS-sensitive mechanism and p38 MAPK inhibitor prevented BMP4-induced endothelial dysfunction. COX-2 inhibition blocked the effect of BMP4 without affecting BMP4-induced ROS overproduction and COX-2 upregulation. Importantly, renal arteries from hypertensive rats and humans showed higher levels of COX-2 and BMP4 accompanied by endothelial dysfunction. Conclusions: We show for the first time that ROS serve as a pathological link between BMP4 stimulation and the downstream COX-2 upregulation in endothelial cells, leading to endothelial dysfunction through ROS-dependent p38 MAPK activation. This BMP4/ROS/COX-2 cascade is important in the maintenance of endothelial dysfunction in hypertension. © 2010 American Heart Association. All rights reserved. | en_HK |
dc.language | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://circres.ahajournals.org | en_HK |
dc.relation.ispartof | Circulation Research | en_HK |
dc.subject | bone morphogenic protein 4 | en_HK |
dc.subject | cyclooxygenase-2 | en_HK |
dc.subject | endothelial dysfunction | en_HK |
dc.subject | endothelium-dependent contractions | en_HK |
dc.subject | reactive oxygen species | en_HK |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Aorta - Metabolism | en_US |
dc.subject.mesh | Bone Morphogenetic Protein 4 - Antagonists & Inhibitors - Metabolism | en_US |
dc.subject.mesh | Bone Morphogenetic Protein Receptors, Type I - Metabolism | en_US |
dc.subject.mesh | Carrier Proteins - Metabolism - Pharmacology | en_US |
dc.subject.mesh | Cyclooxygenase 2 - Genetics - Metabolism | en_US |
dc.subject.mesh | Endothelium, Vascular - Metabolism | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypertension, Renal - Metabolism | en_US |
dc.subject.mesh | Map Kinase Signaling System - Physiology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Mice, Inbred C57bl | en_US |
dc.subject.mesh | Oxidative Stress - Physiology | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, Inbred Shr | en_US |
dc.subject.mesh | Rats, Inbred Wky | en_US |
dc.subject.mesh | Reactive Oxygen Species - Metabolism | en_US |
dc.subject.mesh | Renal Artery - Physiology | en_US |
dc.subject.mesh | Up-Regulation - Drug Effects - Physiology | en_US |
dc.subject.mesh | P38 Mitogen-Activated Protein Kinases - Metabolism | en_US |
dc.title | Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: Implications on hypertension | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Xu, A: amxu@hkucc.hku.hk | en_HK |
dc.identifier.email | Vanhoutte, PM: vanhoutt@hku.hk | en_HK |
dc.identifier.email | Tipoe, GL: tgeorge@hkucc.hku.hk | en_HK |
dc.identifier.authority | Xu, A=rp00485 | en_HK |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_HK |
dc.identifier.authority | Tipoe, GL=rp00371 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1161/CIRCRESAHA.110.222794 | en_HK |
dc.identifier.pmid | 20724703 | - |
dc.identifier.scopus | eid_2-s2.0-77958496539 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-77958496539&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 107 | en_HK |
dc.identifier.issue | 8 | en_HK |
dc.identifier.spage | 984 | en_HK |
dc.identifier.epage | 991 | en_HK |
dc.identifier.isi | WOS:000282965300007 | - |
dc.publisher.place | United States | en_HK |
dc.relation.project | Vascular dysfunction in obesity and diabetes: from risk prediction to therapeutic intervention | - |
dc.identifier.scopusauthorid | Wong, WT=35932584500 | en_HK |
dc.identifier.scopusauthorid | Tian, XY=35768379500 | en_HK |
dc.identifier.scopusauthorid | Chen, Y=24075600300 | en_HK |
dc.identifier.scopusauthorid | Leung, FP=8615375300 | en_HK |
dc.identifier.scopusauthorid | Liu, L=36652673500 | en_HK |
dc.identifier.scopusauthorid | Lee, HK=7501482998 | en_HK |
dc.identifier.scopusauthorid | Ng, CF=8519137200 | en_HK |
dc.identifier.scopusauthorid | Xu, A=7202655409 | en_HK |
dc.identifier.scopusauthorid | Yao, X=7402529434 | en_HK |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_HK |
dc.identifier.scopusauthorid | Tipoe, GL=7003550610 | en_HK |
dc.identifier.scopusauthorid | Huang, Y=7501573013 | en_HK |
dc.identifier.issnl | 0009-7330 | - |